Who owns FORTE BIOSCIENCES INC?
- Ticker: FBRX
- CUSIP Number: 34962g208
Tip: Access positions for across all investors
Analyze quarterly positions in Forte Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Forte Biosciences stock
Who bought or sold FORTE BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 1.8M | $46M | 0% | Mar 2026 |
|
| Fred Alger Management | 1.3M | $33M | -13% | Mar 2026 |
|
| OrbiMed Advisors | 1.2M | $31M | 0% | Mar 2026 |
|
| Henderson Group | 1.2M | $31M | -15% | Mar 2026 |
|
| Affinity Asset Advisors | 1.0M | $28M | 100% | Dec 2025 |
|
| MPM Oncology Impact Management | 1.0M | $26M | 100% | Mar 2026 |
|
| Vanguard Group | 582k | $16M | 3% | Dec 2025 |
|
| Vanguard Capital Management | 532k | $14M | 100% | Mar 2026 |
|
| Morgan Stanley | 500k | $13M | 609% | Mar 2026 |
|
| Cable Car Capital | 400k | $10M | 0% | Mar 2026 |
|
| Millennium Management | 338k | $8.8M | 37% | Mar 2026 |
|
| Adage Capital Partners GP | 333k | $9.1M | 0% | Dec 2025 |
|
| Woodline Partners | 332k | $8.6M | 0% | Mar 2026 |
|
| FMR | 311k | $8.5M | 27% | Dec 2025 |
|
| Citadel Advisors | 233k | $6.0M | 100% | Mar 2026 |
|
| AWM Investment Company | 200k | $5.2M | -16% | Mar 2026 |
|
| Sphera Funds Management | 185k | $4.8M | 0% | Mar 2026 |
|
| Geode Capital Management | 125k | $3.3M | 1% | Mar 2026 |
|
| Ikarian Capital | 119k | $3.1M | -60% | Mar 2026 |
|
| Lord, Abbett & Co | 115k | $3.0M | 100% | Mar 2026 |
|
| Ameriprise Financial | 112k | $2.9M | -27% | Mar 2026 |
|
| Russell Investments | 92k | $2.4M | 100% | Mar 2026 |
|
| Candriam Luxembourg S.C.A. | 85k | $2.2M | 100% | Mar 2026 |
|
| Trexquant Investment | 74k | $1.9M | 470% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 72k | $1.9M | 100% | Mar 2026 |
|
| BlackRock | 66k | $1.7M | 2% | Mar 2026 |
|
| J. Goldman & Co | 61k | $1.7M | 100% | Dec 2025 |
|
| Stempoint Capital | 58k | $1.5M | 100% | Mar 2026 |
|
| Jane Street | 58k | $1.5M | 594% | Mar 2026 |
|
| Goldman Sachs Group | 54k | $1.4M | -21% | Mar 2026 |
|
| Susquehanna International | 53k | $1.4M | 100% | Dec 2025 |
|
| State Street Corporation | 51k | $1.4M | 33% | Dec 2025 |
|
| Marshall Wace | 36k | $990k | 89% | Dec 2025 |
|
| Qube Research & Technologies | 32k | $878k | 100% | Dec 2025 |
|
| Envestnet Asset Management | 29k | $743k | 47% | Mar 2026 |
|
| Northern Trust | 25k | $694k | 9% | Dec 2025 |
|
| Christopher Weil & Company | 25k | $641k | 100% | Mar 2026 |
|
| Barclays | 24k | $658k | 2840% | Dec 2025 |
|
| Bank of America Corporation | 22k | $560k | 100% | Mar 2026 |
|
| Squarepoint Ops | 21k | $538k | 100% | Mar 2026 |
|
| UBS Group | 21k | $530k | -18% | Mar 2026 |
|
| 683 Capital Management | 20k | $518k | -50% | Mar 2026 |
|
| Hudson Bay Capital Management | 19k | $494k | 15% | Mar 2026 |
|
| Balyasny Asset Management | 19k | $485k | 100% | Mar 2026 |
|
| Quadrature Capital | 18k | $479k | 100% | Dec 2025 |
|
| Jain Global | 16k | $404k | -92% | Mar 2026 |
|
| Two Sigma Investments | 16k | $402k | -51% | Mar 2026 |
|
| Brevan Howard Capital Management | 14k | $363k | 100% | Mar 2026 |
|
| Royal Bank of Canada | 13k | $347k | 19% | Mar 2026 |
|
| ALPS Advisors | 10k | $264k | -1% | Mar 2026 |
|
| American Century Companies | 8.1k | $221k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 6.7k | $175k | -34% | Mar 2026 |
|
| Simplex Trading | 6.0k | $164k | 100% | Dec 2025 |
|
| Vanguard Global Advisers | 4.5k | $117k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.4k | $89k | -78% | Mar 2026 |
|
| Global Retirement Partners | 1.0k | $27k | 100% | Dec 2025 |
|
| Tower Research Capital | 773.00 | $21k | 377% | Dec 2025 |
|
| Wells Fargo & Company | 502.00 | $13k | 0% | Mar 2026 |
|
| Fifth Third Bancorp | 496.00 | $13k | 100% | Mar 2026 |
|
| Steward Partners Investment Advisory | 493.00 | $13k | -11% | Mar 2026 |
|
| Group One Trading | 204.00 | $5.3k | 0% | Mar 2026 |
|
| Brian McDonald | 150.00 | $4.1k | 0% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 76.00 | $2.1k | 100% | Dec 2025 |
|
| Assetmark | 46.00 | $1.2k | -21% | Mar 2026 |
|
| SBI Securities | 12.00 | $311.000400 | 0% | Mar 2026 |
|
| REAP Financial Group | 3.00 | $78.000000 | 0% | Mar 2026 |
|
Who sold out of Forte Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Dec 2025 | 487k | $13M |
| Quest Partners | Dec 2025 | 19k | $513k |
| Renaissance Technologies | Sep 2025 | 16k | $243k |
| Landscape Capital Management | Dec 2025 | 16k | $431k |
| OMERS Administration Corporation | Dec 2025 | 16k | $425k |
| ExodusPoint Capital Management | Dec 2025 | 11k | $302k |
| Rockefeller Capital Management | Dec 2025 | 28.00 | $763.999600 |